EUVIMEDEUVIMED entdecken
Crossref

Thymine-functionalized bPEI nanocomplexes for synergistic STING activation and PD-L1 silencing to potentiate cancer immunotherapy

Liqing Chen, Mong-Hsiu Song, Mingji Jin, Heying Jin, Liming Gong, Jing Feng, Yumei Hao, Huihui Shao, Xiaoliang Gong, Zhonggao Gao, Qingyun Yang, Wei Huang

Journal of Controlled Release · 2026-11 · 399 · 115372

DOI: 10.1016/j.jconrel.2026.115372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Liqing Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Polyethyleneimine, RNA, Small Interfering, Membrane Proteins. Die Arbeit nennt 104 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer continues to pose a major global health burden. Although immunotherapy has reshaped treatment strategies, its therapeutic effect is frequently limited by a suppressive tumor microenvironment and systemic toxicity. The stimulator of interferon genes (STING) pathway has emerged as a key target for coordinating innate and adaptive immunity through type I interferon signaling, yet insufficient activation and tumor-intrinsic resistance often constrain its benefit. Herein, we present an innovative branched polyethyleneimine (bPEI)-based nanodelivery platform designed to address these challenges by integrating STING activation with PD-L1 checkpoint blockade. The core of this platform is a novel thymine-functionalized bPEI polymer (bPEI-Thy), which acts as a polyvalent STING agonist and concurrently encapsulates PD-L1 siRNA into well-defined nanocomplexes (named as bPEI-Thy/siPD-L1 NCs, 65.76 nm, PDI 0.193, zeta potential 17.4 mV). In vitro, the NCs were internalized, facilitated endosomal escape, activated STING signaling, and reduced PD-L1 expression. In vivo studies of both anti-PD-L1-responsive and resistant tumor models demonstrated that intratumoral delivery of bPEI-Thy/siPD-L1 NCs substantially reduced tumor growth and metastatic spread, induced apoptosis, alleviated immunosuppression, and extended survival. Mechanistic evaluation showed enhanced dendritic cell maturation, activation of CD4+ and CD8+ T cells together with natural killer cells, an increased M1/M2 macrophage ratio, and reduced Treg infiltration. Notably, unilateral injection also suppressed tumor growth at distant sites, indicating systemic immune activation. Overall, these dual-functional bPEI-Thy/siPD-L1 NCs provide an integrated platform that activates innate immune pathways and blocks adaptive immune checkpoint blockade, offering a safe and effective strategy for synergistic cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenPolyethyleneimineRNA, Small InterferingMembrane ProteinsNanoparticlesNeoplasmsAnimalsSTING ProteinImmunotherapyHumanscGAS-STING Signaling PathwayMiceCell Line, TumorMice, Inbred C57BLFemale

Stichwörter der Autor:innen

PD-L1 silencingPEI derivativesPolyvalent STING agonistTumor immunotherapy

Substanzen

B7-H1 AntigenPolyethyleneimineSTING ProteinRNA, Small InterferingMembrane ProteinsSting1 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Beijing Key Laborato…
  • Xiangya Medical College, Central South University, Changsha 410043, China.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Electronic address:…

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chen, L., Song, M. H., Jin, M., Jin, H., Gong, L., Feng, J., Hao, Y., Shao, H., Gong, X., Gao, Z., Yang, Q., & Huang, W. (2026). Thymine-functionalized bPEI nanocomplexes for synergistic STING activation and PD-L1 silencing to potentiate cancer immunotherapy. Journal of Controlled Release, 399, 115372. https://doi.org/10.1016/j.jconrel.2026.115372

Vancouver

Chen L, Song MH, Jin M, Jin H, Gong L, Feng J, et al. Thymine-functionalized bPEI nanocomplexes for synergistic STING activation and PD-L1 silencing to potentiate cancer immunotherapy. Journal of Controlled Release. 2026;399:115372. doi:10.1016/j.jconrel.2026.115372

BibTeX
@article{Chen2026,
  author = {Chen, Liqing and Song, Mong-Hsiu and Jin, Mingji and Jin, Heying and Gong, Liming and Feng, Jing and Hao, Yumei and Shao, Huihui and Gong, Xiaoliang and Gao, Zhonggao and Yang, Qingyun and Huang, Wei},
  title = {Thymine-functionalized bPEI nanocomplexes for synergistic STING activation and PD-L1 silencing to potentiate cancer immunotherapy},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115372},
  doi = {10.1016/j.jconrel.2026.115372}
}
Kostenlos starten →